| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/08/2004 | WO2003068812A3 Immune-modulating peptide made of s. aureus enterotoxin b |
| 01/08/2004 | WO2003067262A3 Methods and compositions involving the hsp90 activator aha1 |
| 01/08/2004 | WO2003054194A3 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 01/08/2004 | WO2003042233A3 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry |
| 01/08/2004 | WO2003020876A3 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 01/08/2004 | WO2003007890A3 Tropomyosin isoforms, and diagnostic and therapeutic uses therefor |
| 01/08/2004 | WO2003000859A3 G-protein coupled receptors |
| 01/08/2004 | WO2002103016B1 Human tachykinin-related splice variants and compositions thereof |
| 01/08/2004 | WO2002095067A3 INTERFERON α-14 POLYMORPHISM |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | WO2002068650B1 Modified and stabilized gdf propeptides and uses thereof |
| 01/08/2004 | WO2002059310A3 Polynucleotides encoding cellular transporters and methods of use thereof |
| 01/08/2004 | WO2002053596A3 Antibodies to insulin-like growth factor i receptor |
| 01/08/2004 | WO2002044373A3 Adipocyte complement related protein zacrp12 |
| 01/08/2004 | WO2000052135A3 Engineering intracellular sialylation pathways |
| 01/08/2004 | US20040006792 Soybean seeds exhibiting oil composition which comprises varying concentrations of oleic acid, linoleic acid, linolenic acid and saturated fatty acids; vegetable oils |
| 01/08/2004 | US20040006779 Antibodies against gene products related to werner's syndrome |
| 01/08/2004 | US20040006778 Comprises heat resistant polypeptide for preparing pharmaceuticals; drug biosynthesis; side effect reduction |
| 01/08/2004 | US20040006776 Transgenic production of antibodies in milk |
| 01/08/2004 | US20040006219 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006217 Comprises coagulation factor VIIa/VII receptor for treatment and prevention of thrombosis, septic shock and adult respiratory distress syndrome (ARDS); anticoagulants; thrombolytic agents |
| 01/08/2004 | US20040006216 Comprises immunoglobulin for treating cancer; immunosuppressant; immunotherapy |
| 01/08/2004 | US20040006215 Human monoclonal antibodies against CD30 |
| 01/08/2004 | US20040006211 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006209 Comprises immunoglobulin which specifically binds staphylococcal g-protein and receptor sites for preventing and treating infections; gentic vaccines |
| 01/08/2004 | US20040006207 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 01/08/2004 | US20040006206 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/08/2004 | US20040006022 For therapy of autoimmune or an inflammatory disease |
| 01/08/2004 | US20040005683 Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 01/08/2004 | US20040005671 Immunointeractive molecules |
| 01/08/2004 | US20040005665 Comprises nucleotide sequences coding membrane proteins for diagnosing, preventing and treating inflammatory, tumorous and nervous system disorders |
| 01/08/2004 | US20040005662 Culuring transgenic cells which codes bactericides; genetic vaccines |
| 01/08/2004 | US20040005660 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/08/2004 | US20040005643 Anti-human tenascin monoclonal antibody |
| 01/08/2004 | US20040005633 Using chromatography to separate and sort subsets of peptides in protein mixtures |
| 01/08/2004 | US20040005630 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 01/08/2004 | US20040005626 Comprises nucleotide sequences coding membrane protein for diagnosing and treating inflammatory and tumor disorders |
| 01/08/2004 | US20040005604 Comprises nucleotide sequences coding enzymatic polypeptide for degumming oil and food processing; antisense therapy |
| 01/08/2004 | US20040005600 Designing expression vector for improved accumulation of plasmodium protein in transformed cells |
| 01/08/2004 | US20040005598 Comprises nucleotide sequences coding protein upregulated in metastatic prostate cancer (PUMPCn) for diagnosis and treatment of tumors; antiproliferative agents; anticarcinogenic agents |
| 01/08/2004 | US20040005581 Comprises nucleotide sequences coding vanilloid receptor-like receptor (VR4) for diagnosing and treating pain, inflammation, neurodegeneration, cardiovascular, cancer and urogenital diseases; drug screening |
| 01/08/2004 | US20040005579 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005577 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005576 Comprises polypeptides for diagnosing, prognosing and preventing cancer, nervous system, developmental and metabolic disorders |
| 01/08/2004 | US20040005575 Nucleic acids, proteins, and antibodies |
| 01/08/2004 | US20040005561 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 01/08/2004 | US20040005553 Comprises membrane protein for treating cancer, inflammation and autoimmune disorders |
| 01/08/2004 | US20040005332 Application is described the expression and purification of a recombinant Plasmodium falciparum (FVO) MSP-142. The method of the present invention produces a highly purified protein that retains folding and disulfide bridging of the native |
| 01/08/2004 | US20040005328 Novel antigens of B. catarrhalis are provided, together with their use in vaccines as well as methods of diagnosing and/or detection. Branhamella catarrhalis (also known as Moraxella catarrhalis) is a gram-negative aerobic bacterium that causes |
| 01/08/2004 | US20040005323 Efficient method for generating human antibodies in particular which are specific to be RSV fusion protein which combines in vitro primary of human spleen cells and antigen boosting in SCID mice is taught. This method provides for very high human |
| 01/08/2004 | US20040005321 Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotheraphy |
| 01/08/2004 | US20040005316 Use of HMG fragments as anti-inflammatory agents |
| 01/08/2004 | US20040005276 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
| 01/08/2004 | CA2491861A1 Human igm antibody lysing activated lymphocytes under mediation by homologous complement |
| 01/08/2004 | CA2491363A1 Antibodies and uses thereof |
| 01/08/2004 | CA2491212A1 Protein production methods and modified cells for use therein |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490409A1 Mammalian ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490348A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/08/2004 | CA2490290A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 01/08/2004 | CA2490283A1 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 01/08/2004 | CA2490256A1 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 01/08/2004 | CA2486543A1 Pesticidally active proteins and polynucleotides obtainable from paenibacillus species |
| 01/07/2004 | EP1378573A1 Interleukin 1 beta protease and interleukin 1 beta protease inhibitors |
| 01/07/2004 | EP1378572A1 Bmp-11 compositions |
| 01/07/2004 | EP1378571A1 5' ESTs for secreted proteins expressed in various tissues |
| 01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 01/07/2004 | EP1378525A2 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods |
| 01/07/2004 | EP1378524A2 Recombinant thrombin receptor antibodies and their use |
| 01/07/2004 | EP1378522A2 Methods of enhancing bioactivity of chemokines |
| 01/07/2004 | EP1378517A1 Phosphoinositolglycan (PIG) binding protein from adipocytes |
| 01/07/2004 | EP1378245A2 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis. Their use in a vaccine |
| 01/07/2004 | EP1377833A2 Gastrointestinal glutathione peroxidase in hepatitis c virus infections |
| 01/07/2004 | EP1377608A1 Insulin precursors and a process for their preparation |
| 01/07/2004 | EP1377606A1 Immunogenic cell surface proteins of helicobacter pylori |
| 01/07/2004 | EP1377603A1 Protein cluster v |
| 01/07/2004 | EP1377314A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 01/07/2004 | EP1377251A2 A cell therapy method for the treatment of tumors |
| 01/07/2004 | EP1227736B1 Protein hydrolysates produced with the use of marine proteases |
| 01/07/2004 | EP1034187B1 Growth-promoting proteins and peptides for kidney epithelial cells |
| 01/07/2004 | EP1021556B1 Assay using marked microbial host cell strains |
| 01/07/2004 | EP0647270B1 Novel malignant cell type markers of the interior nuclear matrix |
| 01/07/2004 | EP0600880B1 Interleukin 1- beta protease and interleukin 1-beta protease inhibitors |
| 01/07/2004 | CN1466682A HCV antigen/antibody combination assay |
| 01/07/2004 | CN1466631A Process for producing protein decomposition product |
| 01/07/2004 | CN1466628A A method of extracellular production of target proteins employing OmpF in e coli |
| 01/07/2004 | CN1466626A Production process of subtilin surfactin |
| 01/07/2004 | CN1465703A Synthesis, expression, preparation and application for human parathyroid hormone gene mutant |
| 01/07/2004 | CN1465595A Mouse histone human endostatin monoclone antibody |
| 01/07/2004 | CN1465591A Affinity functional zone cell anchoring factor for amino acid sequence arginine-glycine-aminosuccinic acid/cellulose and preparation method thereof |
| 01/07/2004 | CN1465590A Recombination main outer membrane protein of parrot fever chlaydozoan, and preparation process and use thereof |
| 01/07/2004 | CN1465587A Polypeptide-chondriosome carrier 18 and polynucleotide for colding said polypeptide |
| 01/07/2004 | CN1465402A Recombination protein vaccine for preventing animal aphtha virus infection |
| 01/07/2004 | CN1133652C Process for preparing collagen |
| 01/06/2004 | US6673913 GANP proteins |
| 01/06/2004 | US6673903 Antiproliferative agents |
| 01/06/2004 | US6673899 Protein for use treatment of diabetes |
| 01/06/2004 | US6673895 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 01/06/2004 | US6673609 Diagnosing anemia |
| 01/06/2004 | US6673591 Increasing permissiveness of cell to viral replication by decreasing expression of interferon by making cell deficient in factor that regulates interferon expression in vivo |